Literature DB >> 11010834

Role of animal models in understanding intravesical therapy with bacille Calmette-Guérin.

T L Ratliff1.   

Abstract

Animal models provide a vehicle for understanding basic biological questions. Through the use of animal models, adequate control of experimental design is possible so that rigorous experiments can be performed to test a hypothesis. In the case of testing therapeutic mechanisms, it is important to select a model that is most analogous to the clinical setting so that observations can be readily transferred to clinical studies for validation. In mechanistic studies of Mycobacterium bovis strain (bacille Calmette-Guérin) therapy for bladder cancer, the orthotopic animal model most closely mimics the clinical treatment of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11010834     DOI: 10.1086/314065

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model.

Authors:  Masashi Matsushima; Minoru Horinaga; Ryuichi Fukuyama; Hitoshi Yanaihara; Eiji Kikuchi; Makoto Kawachi; Masahiro Iida; Yoko Nakahira; Mototsugu Oya; Hirotaka Asakura
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

2.  IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer.

Authors:  J Riemensberger; A Böhle; S Brandau
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Intravesical Bacillus Calmette-Guerin and its complications: 12 years of learning experience in a single local institution.

Authors:  XinYan Yang; Qi Toh; Hong Hong Huang; Li-Hwei Sng; Thuan Tong Tan; Lay Guat Ng
Journal:  Singapore Med J       Date:  2020-12-02       Impact factor: 3.331

4.  Tumor establishment features of orthotopic murine bladder cancer models.

Authors:  Jin Seok Lee; Min Ho Bae; Sung Ho Choi; Sang Hun Lee; Young Sam Cho; Heung Jae Park; Chil Hun Kwon; Kwan Joong Joo
Journal:  Korean J Urol       Date:  2012-06-19

5.  1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.

Authors:  Jong-Wei Hsu; Peng-Nien Yin; Ronald Wood; James Messing; Edward Messing; Yi-Fen Lee
Journal:  Oncotarget       Date:  2013-12

6.  Therapeutic Effect on Bladder Cancer with a Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex Virus.

Authors:  Kwan Joong Joo; Hongtao Li; Xiaoliu Zhang; Seth P Lerner
Journal:  Bladder Cancer       Date:  2015-04-30

7.  Indoleamine 2,3-Dioxygenase-1 Expression is Changed During Bladder Cancer Cell Invasion.

Authors:  Hellen Joyce Sousa Pereira Santos; Luiz Henrique Gomes Matheus; Aline Silva; Stephanie Vanin Dalmazzo; Andressa Assunção Santos; Letícia Rafaela Alves Rubens Santos; Diego Mota Souza; Sabrina Thalita Reis; Ivan Pereira Nascimento; Humberto Dellê
Journal:  Int J Tryptophan Res       Date:  2022-01-04

8.  Establishment of an optimized orthotopic bladder cancer model in mice.

Authors:  Jinming Cai; Zhiwen Xie; Yilin Yan; Zhengnan Huang; Pengfei Tang; Xiangqian Cao; Zeyi Wang; Chenkai Yang; Mingyue Tan; Fang Zhang; Bing Shen
Journal:  BMC Urol       Date:  2022-09-03       Impact factor: 2.090

9.  Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model.

Authors:  Daher C Chade; Ricardo C Borra; Ivan P Nascimento; Fabiola E Villanova; Luciana C C Leite; Enrico Andrade; Miguel Srougi; Kátia L Ramos; Priscila M Andrade
Journal:  J Exp Clin Cancer Res       Date:  2008-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.